Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: A novel drug carrier for cancer targeting therapy

British Journal of Cancer

Volumn 81, Issue 7, 1999, Pages 1155-1161

  Tsunoda, S ^a   Ohizumi, I ^b   Matsui, J ^a   Koizumi, K ^a   Wakai, Y ^a   Makimoto, H ^a   Tsutsumi, Y ^a   Utoguchi, N ^c   Taniguchi, K ^b   Saito, H ^b   Harada, N ^b   Ohsugi, Y ^b   Mayumi, T ^a  

^a OSAKA UNIVERSITY   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Drug delivery system; Immunoconjugate; Monoclonal antibody; Targeting therapy; Tumour vascular endothelium

Indexed keywords

ANTIBODY CONJUGATE; CANCER ANTIBODY; DRUG CARRIER; IODINE 125; ZINOSTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TARGETING; ESOPHAGUS CANCER; FEMALE; FIBROSARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION; TISSUE NECROSIS; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

EID: 0032712235     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690823     Document Type: Article

References (37)

1. Brooks PC, Clark RA and Cheresh DA (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264: 569-571
2. Brown JP, Woodbury RG, Hart CE, Hellstrom I and Hellstrom KE (1981) Quantitative analysis of melanoma associated antigen p97 in normal neoplastic tissues. Proc Natl Acad Sci USA 78: 539-543
3. Burrows FJ and Thorpe PE (1993) Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc Natl Acad Sci USA 90: 8996-9000
4. 11In-labeled B3 monoclonal antibody: biodistribution and imaging studies in nude mice bearing human epidermoid carcinoma xenografts. Cancer Res 53: 2834-2839
5. Denekamp J (1984) Vasculature as a target for tumor therapy. Prog Appl Microcirc 4: 28-38
6. Dvorak HF, Nagy JA, Dvorak JT and Dvorak AM (1988) Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 133: 95-109
7. Dvorak HF, Nagy JA and Dvorak AM (1991) Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells 3: 77-85
8. Epenetos AA, Snook D, Durbin H, Johnson PM and Taylor-Papadimitriou J (1986) Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms. Cancer Res 46: 3183-3191
9. Friden PM, Walus LR, Watson P, Doctrow SR, Kozarich JW, Backman C, Bergman H, Hoffer B, Bloom F and Granholm AC (1993) Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259: 373-378
10. Griffioen AW, Damen CA, Blijham GH and Groenewegen G (1996a) Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood 88: 667-673
11. Griffioen AW, Damen CA, Martinotti S, Blijham GH and Groenewegen G (1996b) Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. Cancer Res 56: 1111-1117
12. Haranaka K, Satomi N and Sakurai A (1984) Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer 34: 263-267
13. Hellstrom KE and Hellstrom I (1985) Monoclonal anti-melanoma antibodies and their possible clinical use. In: Monoclonal Antibodies for Cancer Detection and Therapy, Baldwin RW and Byerrs VS (eds). pp. 17-51. Academic Press: London
14. Heuser LS and Miller FN (1986) Differential macromolecular leakage from the vasculature of tumors. Cancer 57: 461-464
15. Juweid M, Neumann R, Paik C, Perez-Bacete MJ, Sato J, vanOsdol W and Weinstein JN (1992) Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res 52: 5144-5153
16. Kennel SJ, Falcioni R and Wesley JW (1991) Microdistribution of specific rat monoclonal antibodies to mouse tissues and human xenografts. Cancer Res 51: 1529-1536
17. Kitamura K, Takahashi T, Kotani T, Miyagaki T, Yamaoka N, Tsurumi H, Noguchi A and Yamaguchi T (1992) Local administration of monoclonal antibody drug conjugate: a new strategy to reduce the local recurrence of colorectal cancer. Cancer Res 52: 6323-6328
18. Laborda J, Douillard JY, Burg C, Lizzio EF, Ridge J, Levenbook I and Hoffman T (1990) Pharmacokinetic studies of mouse monoclonal antibodies to a rat colon carcinoma: I. Comparison of biodistribution in normal rats, syngeneic tumor-bearing rats, or tumor-bearing nude mice. J Nucl Med 31: 1028-1034
19. Madri JA and Williams SK (1983) Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol 97: 153-165
20. Manda T, Shimomura K, Mukumoto S, Kobayashi K, Mizota T, Hirai O, Matsumoto S, Oku T, Nishigaki F and Mori J (1987) Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity. Cancer Res 47: 3707-3711
21. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL and Jain RK (1996) During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 2: 992-997
22. Modzelewski RA, Davies P, Watkins SC, Auerbach R, Chang MJ and Johnson CS (1994) Isolation and identification of fresh tumor derived endothelial cells from a murine RIF-1 fibrosarcoma. Cancer Res 54: 336-339
23. Nose K, Saito H and Kuroki T (1990) Isolation of a gene sequence induced later by tumor-promoting 12-O-tetradecanoylphorbol-13-acetate in mouse osteoblastic cells (MC3T3-E1) and expressed constitutively in ras-transformed cells. Cell Growth Differ 1: 511-518
24. Ohizumi I, Tsunoda S, Taniguchi K, Saito H, Esaki K, Makimoto H, Wakai Y, Tsutsumi Y, Nakagawa S, Utoguchi N, Kaiho S, Ohsugi Y and Mayumi T (1997) Antibody-based therapy targeting tumor vascular endothelial cells suppresses solid tumor growth in rats. Biochem Biophys Res Commun 236: 493-496
25. Ohizumi I, Tsunoda S, Taniguchi K, Saito H, Esaki K, Koizumi K, Makimoto H, Wakai Y, Matsui J, Tsutsumi Y, Nakagawa S, Utoguchi N, Ohsugi Y and Mayumi T (1998) Monoclonal antibodies recognize antigens expressed on rat tumor vasculature. Int J Cancer 77: 561-566
26. Pai LH, Wittes R, Setser A, Willingham MC and Pastan I (1996) Treatment of advanced solid tumors with immunotoxin LMB-1: An antibody linked to Pseudomonas exotoxin. Nat Med 3: 350-353
27. Reiter Y, Pai LH, Brinkmann U, Wang Q and Pastan I (1994) Antitumor activity and pharmacokinetics in mice of recombinant immunotoxin containing a disulfide stabilized Fv fragment. Cancer Res 54: 2714-2718
28. Rettig WJ, Garin-Chesa P, Healey JH, Su SL, Jaffe EA and Old LJ (1992) Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc Natl Acad Sci USA 89: 10832-10836
29. Rowland GF (1987) Monoclonal antibodies as carriers for drug delivery systems. In: Drug Delivery Systems: Fundamentals and Techniques, Johnson P and Lloyd-Jones JG (eds). pp. 81-94. VCH Publishers: Chichester
30. Scott RE (1976) Plasma-membrane vesiculation: a new technique for isolation of plasma membranes. Science 194: 743-745
31. Takahashi T, Yamaguchi T, Kitamura K, Noguchi A, Honda M and Otsuji E (1990) Missile therapy for colorectal and pancreatic cancers: clinical trial of monoclonal antibody, A7-NCS, for 73 patients with colorectal and pancreatic cancers. Jpn J Cancer Chemother 17: 1111-1119
32. Thorpe PE and Burrows FJ (1995) Antibody-directed targeting of the vasculature of solid tumors. Breast Cancer Res Treat 36: 237-251
33. Utoguchi N, Dantakean A, Makimoto H, Wakai Y, Tsutsumi Y, Nakagawa S and Mayumi T (1995a) Isolation and properties of tumor-derived endothelial cells from rat KMT-17 fibrosarcoma. Jpn J Cancer Res 86: 193-201
34. Utoguchi N, Mizuguchi H, Sacki K, Ikeda K, Tsutsumi Y, Nakagawa S and Mayumi T (1995b) Tumor-conditioned medium increases macromolecular permeability of endothelial cell monolayer. Cancer Lett 89: 7-14
35. Utoguchi N, Mizuguchi H, Dantakean A, Makimoto H, Wakai Y, Tsutsumi Y, Nakagawa S and Mayumi T (1996) Effect of tumour cell-conditioned medium on endothelial macromolecular permeability and its correlation with collagen. Br J Cancer 73: 24-28
36. Watanabe N, Niitsu Y, Umeno H, Sone H, Neda H, Yamauchi N, Maeda M and Urushizaki I (1988) Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia. Cancer Res 48: 650-653
37. Wu NZ, Klitzman B, Dodge R and Dewhirst MW (1992) Diminished leukocyte-endothelium interaction in tumor microvessels. Cancer Res 52: 4265-4268